Keytruda

News

Merck bags adjuvant okay for Keytruda in melanoma

Checkpoint inhibitors have already revolutionised the treatment of advanced melanoma, and Merck & Co has just claimed approval for even earlier use of its Keytruda product in Europe.

Views & Analysis

Merck & Co’s cancer blockbuster Keytruda funds cutting edge ...

Merck & Co is enjoying blockbuster revenues as its cancer immunotherapy Keytruda is becoming standard of care in a range of cancers.

News

Merck gets FDA okay for Keytruda as liver cancer therapy

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ri

News

Keytruda approved for combination lung cancer therapy

The US Food and Drug Administration (FDA) has approved Merck & Co’s Keytruda plus chemotherapy as a first-line treatment for non-small cell lung cancer (NSCLC).

News

Merck & Co's Keytruda shows potential in head and neck cance...

Merck & Co might be able to find another use for its immunotherapy Keytruda in first line head and neck cancer, after revealing promising phase 3 trial results.

News

FDA approves Keytruda in cervical cancer

Merck & Co’s blockbuster Keytruda has been approved in advanced second line cervical cancer, becoming the first drug in its class approved in the indication.

Merck bags adjuvant okay for Keytruda in melanoma

Merck & Co’s cancer blockbuster Keytruda funds cutting edge ...

Merck gets FDA okay for Keytruda as liver cancer therapy

Keytruda approved for combination lung cancer therapy

Merck & Co's Keytruda shows potential in head and neck cance...

FDA approves Keytruda in cervical cancer

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Keytruda

Editor's Picks